{"DataElement":{"publicId":"2668237","version":"1","preferredName":"Cancer Identification Histology ICD-O-2 Code","preferredDefinition":"Codes for the histologic type of the tumor being reported using ICD-O-2.","longName":"2668215v1.0:2644361v1.0","context":"PS-CC","contextVersion":"1","DataElementConcept":{"publicId":"2668215","version":"1","preferredName":"Cancer Identification Histology ICD-O-2","preferredDefinition":"The histologic type of the tumor being reported using ICD-O-2.","longName":"2666870v1.0:2668213v1.0","context":"PS-CC","contextVersion":"1","ObjectClass":{"publicId":"2666870","version":"1","preferredName":"Malignant Neoplasm Identified","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004:Identified; having the identity known or established.","longName":"C9305:C25737","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Identification","conceptCode":"C25737","definition":"The procedure of having an identity established.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"36033E9E-8A70-432F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2007-07-24","modifiedBy":"ONEDATA","dateModified":"2007-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2668213","version":"1","preferredName":"Histology International Classification of Disease for Oncology","preferredDefinition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.:The International Classification of Disease for Oncology has been used for nearly 25 years as a tool for coding diagnoses of neoplasms in tumor and cancer registrars and in pathology laboratories. ICD-O is a dual classification with coding systems for both topography and morphology. The topography code describes the site of origin of the neoplasm. The morphology code describes the characteristics of the tumor itself, including its cell type and biologic activity. (from Amazon.com)","longName":"C16681:C37978","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"International Classification of Diseases for Oncology","conceptCode":"C37978","definition":"The International Classification of Diseases for Oncology has been used for nearly 25 years as a tool for coding diagnoses of neoplasms in tumor and cancer registrars and in pathology laboratories. ICD-O is a dual classification with coding systems for both topography and morphology. The topography code describes the site of origin of the neoplasm. The morphology code describes the characteristics of the tumor itself, including its cell type and biologic activity. (from Amazon.com)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"362ED752-18E1-0628-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2007-07-26","modifiedBy":"ONEDATA","dateModified":"2007-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435032","version":"1","preferredName":"Property or Attribute","preferredDefinition":"The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","longName":"C20189","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-8321-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"362ED752-18F2-0628-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2007-07-26","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2644361","version":"1","preferredName":"Histology International Classification of Diseases Oncology 2 (ICD-O-2) Code","preferredDefinition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (from ICD-10, p1). The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S. (MSH2005_2004_10_12)_The study of tumors encompassing the physical, chemical, and biologic properties._A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one_A system of numbered categories for representation of data. [Explanatory Comment: See ICD-O-2 Histology Section for codes.].","longName":"2644361v1.0","context":"PS-CC","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":"4","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2435030","version":"1","preferredName":"NCI Administrative Concept","preferredDefinition":"Conceptual entities required by NCI operations and systems. Includes administrative, financial, organizational and quasi-scientific concepts required for NCI operations and systems. ","longName":"C28389","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07432182-1611-25E9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"14483789","version":"1","preferredName":"Histology International Classification of Diseases Oncology Two Code","preferredDefinition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization. The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S._The study of tumors encompassing the physical, chemical, and biologic properties._A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"14483789v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"International Classification of Diseases","conceptCode":"C49474","definition":"A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization. The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Oncology","conceptCode":"C17837","definition":"The study of tumors encompassing the physical, chemical, and biologic properties.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Two","conceptCode":"C66833","definition":"A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05C987E5-63F1-74D9-E063-731AD00AE33E","latestVersionIndicator":"Yes","beginDate":"2023-09-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-20","modifiedBy":"KUMMEROA","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31509A31-F0D7-477F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-25","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-05-25","modifiedBy":"KUMMEROA","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":"2023.9.20 Updated def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2193114","version":"1","longName":"Division of Cancer Control and Population Sciences","context":"PS-CC","ClassificationSchemeItems":[{"publicId":"3134707","version":"1","longName":"NAACCR 12.1","context":"PS-CC"},{"publicId":"3134731","version":"1","longName":"CancerID12.1","context":"PS-CC"},{"publicId":"3103505","version":"1","longName":"NAACCR 11.1","context":"PS-CC"},{"publicId":"3103520","version":"1","longName":"CancerID11.1","context":"PS-CC"},{"publicId":"3103506","version":"1","longName":"NAACCR 11.2","context":"PS-CC"},{"publicId":"3103521","version":"1","longName":"CancerID11.2","context":"PS-CC"},{"publicId":"3103507","version":"1","longName":"NAACCR 11.3","context":"PS-CC"},{"publicId":"3103537","version":"1","longName":"CancerID11.3","context":"PS-CC"},{"publicId":"5899833","version":"1","longName":"NAACCR 16","context":"PS-CC"},{"publicId":"5899834","version":"1","longName":"CancerID16","context":"PS-CC"},{"publicId":"7464307","version":"1","longName":"CancerID18","context":"PS-CC"},{"publicId":"7464305","version":"1","longName":"NAACCR 18","context":"PS-CC"}]}],"AlternateNames":[{"name":"420","type":"NAACCR Item #","context":"PS-CC"},{"name":"HISTOLOGY (92-00) ICD-O-2","type":"NAACCR Item Name","context":"PS-CC"},{"name":"Histology (COC)","type":"NAACCR Alt Name","context":"PS-CC"},{"name":"ICD-O-2 Histology (CCCR)","type":"NAACCR Alt Name","context":"PS-CC"},{"name":"Histology (CoC)","type":"NAACCR Alt Name","context":"PS-CC"},{"name":"Histology (92-00) ICD-O-2","type":"NAACCR Item Name","context":"PS-CC"}],"ReferenceDocuments":[{"name":"Histology (92-00) ICD-O-2","type":"Preferred Question Text","description":"Histology (92-00) ICD-O-2","url":null,"context":"PS-CC"},{"name":"NAACCR, V 11.1 Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.1 Data Standards and Data Dictionary (5/4/06)","url":"http://www.naaccr.org/filesystem/pdf/Volume%20II%20Version%2011.1.pdf","context":"PS-CC"},{"name":"Codes","type":"VALID_VALUE_SOURCE","description":"See ICD-O-2 Histology Section for codes.","url":null,"context":"PS-CC"},{"name":"Histology (92-00) ICD-O-2 Description","type":"COMMENT","description":"NAACCR adopted ICD-O-2 as the standard coding system for tumors diagnosed in 1992 and later and recommended that prior cases be converted to ICD-O-2. See Histology (73-91) ICD-O-1 [1971] for ICD-0-1 and field trial codes.","url":null,"context":"PS-CC"},{"name":"NAACCR V11.2 Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.2 Data Standards and Data Dictionary (5/30/2007)","url":"http://www.naaccr.org/LinkClick.aspx?fileticket=PQdlAnykU1U%3d","context":"PS-CC"},{"name":"NAACCR V11.3 Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.3 Data Standards and Data Dictionary (4/2008)","url":"http://www.naaccr.org/LinkClick.aspx?fileticket=xSH32ZzIzGI%3d","context":"PS-CC"},{"name":"NAACCR 12.1, Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 12.1 Data Standards and Data Dictionary (6/2010)","url":"http://www.naaccr.org/LinkClick.aspx?fileticket=LJJNRVo4lT4%3d&tabid=133&mid=473","context":"PS-CC"},{"name":"NAACCR 16, Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)","url":"https://www.naaccr.org/data-standards-data-dictionary/","context":"PS-CC"}],"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"36301C87-09E5-212D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2007-07-26","modifiedBy":"HARTLEYG","dateModified":"2018-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}